Mankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...

Indian Hotels Company Limited (IHCL) is set to invest between Rs 6,000 crore and Rs 7,500 crore in capital expenditure over the next five y...

Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...

Mankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...

Walt Disney's Star Group injected Rs 123 crore into JioStar India via FDI, bolstering the Reliance-Disney joint venture. This follows subst...

Donald Trump's tariffs, once feared to cripple markets, have had a surprisingly muted impact, with actual levies lower than headline rates....

Tamil Nadu-based Stalwart People Services has filed its DRHP with Sebi to raise Rs 150 crore through a fresh issue of shares, alongside an ...

In its UDRHP-I filing to Sebi, the company any 'adverse' outcome in legal proceedings involving Zostel may materially and adversely affect ...

Indian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...

Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...

The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...

Strides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...

At this point, it would be good to keep some powder dry and focus on the fundamentals of sectors, especially those where underlying changes...

India needs to add nearly 2,000 gigawatts of new power generation capacity over the next two decades to meet rising demand and reduce relia...

Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...

Indian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...